Canada markets closed

Entheon Biomedical Corp. (ENTBF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0231-0.0019 (-7.54%)
At close: 03:14PM EST

Entheon Biomedical Corp.

999 West Broadway
Suite 720
Vancouver, BC V5Z 1K5
Canada
604-562-3932
https://www.entheonbiomedical.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees3

Key Executives

NameTitlePayExercisedYear Born
Mr. Timothy KoPres, CEO & Director98.36kN/A1986
Mr. Brandon Schwabe C.P.A., CGAChief Financial Officer80.95kN/A1986
Dr. Andrew Peter Hegle Ph.D.Chief Science Officer, Director of Operations & Director88.25kN/A1979
Dr. Brian E. Jahns Pharm.D.Chief Bus. OfficerN/AN/AN/A
Ms. Kelly PladsonCorp. Sec.N/AN/A1983
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Entheon Biomedical Corp. operates as a biotechnology research and drug development company. It engages in developing and commercializing various N,N-dimethyltryptamine based psychedelic therapeutic products for treating addiction and substance use disorders. The company serves physicians, clinics, and licensed psychiatrists in Canada, the United States, and European Union. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.

Corporate Governance

Entheon Biomedical Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.